Apellis Pharmaceuticals, Inc.

NEW YORK STATE COMMON RETIREMENT FUND APLS

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/12/2026

Shares

104,018

Value ($000)

2,613

Weight

0.0%

2019 Q4 - 2025 Q4 (25 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/12/2026	2,613	0.0%	104,018	12/31/2025
2025 Q3	11/3/2025	1,105	0.0%	48,837	9/30/2025
2025 Q2	10/8/2025	1,019	0.0%	58,879	6/30/2025
2025 Q1	10/8/2025	1,068	0.0%	48,837	3/31/2025
2024 Q4	10/8/2025	1,558	0.0%	48,837	12/31/2024
2024 Q3	10/8/2025	10,862	0.0%	376,613	9/30/2024
2024 Q2	10/8/2025	16,537	0.0%	431,113	6/30/2024
2024 Q1	10/8/2025	19,158	0.0%	325,926	3/31/2024
2023 Q4	10/8/2025	20,383	0.0%	340,507	12/31/2023
2023 Q3	10/8/2025	15,328	0.0%	402,944	9/30/2023
2023 Q2	10/8/2025	27,421	0.0%	300,995	6/30/2023
2023 Q1	10/8/2025	16,036	0.0%	243,120	3/31/2023
2022 Q4	10/8/2025	5,400	0.0%	104,420	12/31/2022
2022 Q3	11/8/2022	10,242	0.0%	149,954	9/30/2022
2022 Q2	8/4/2022	4,129	0.0%	91,306	6/30/2022
2022 Q1	7/1/2022	3,947	0.0%	77,691	3/31/2022
2021 Q4	2/2/2022	3,112	0.0%	65,814	12/31/2021
2021 Q3	11/2/2021	1,549	0.0%	47,004	9/30/2021
2021 Q2	8/2/2021	4,283	0.0%	67,765	6/30/2021
2021 Q1	5/11/2021	2,360	0.0%	55,000	3/31/2021
2020 Q4	2/8/2021	3,586	0.0%	62,685	12/31/2020
2020 Q3	11/5/2020	1,659	0.0%	55,000	9/30/2020
2020 Q2	8/7/2020	1,796	0.0%	55,000	6/30/2020
2020 Q1	5/6/2020	1,358	0.0%	50,700	3/31/2020
2019 Q4	2/5/2020	1,329	0.0%	43,400	12/31/2019